We are live on ! Find out more
RP

Rowlandmiller & Partners Portfolio holdings

AUM $549M
1-Year Est. Return 36.2%
This Fund
S&P 500
This Quarter Est. Return
+7.71%
1 Year Est. Return
+36.2%
3 Year Est. Return
+84%
5 Year Est. Return
+107.35%
10 Year Est. Return
+338.51%
AUM
$509M
AUM Growth
+$24.6M
Cap. Flow
-$4.38M
Cap. Flow %
-0.86%
Top 10 Hldgs %
38.32%
Holding
194
New
7
Increased
51
Reduced
69
Closed
7

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$873K
2
VZ icon
Verizon
VZ
+$843K
3
COST icon
Costco
COST
+$754K
4
UNH icon
UnitedHealth
UNH
+$668K
5
SWKS icon
Skyworks Solutions
SWKS
+$579K

Top Sells

Rank Stock Value
1
PGR icon
Progressive
PGR
+$1.49M
2
MSFT icon
Microsoft
MSFT
+$1.48M
3
LLY icon
Eli Lilly
LLY
+$1.25M
4
WMT icon
Walmart Inc
WMT
+$648K
5
JNJ icon
Johnson & Johnson
JNJ
+$529K

Sector Composition

Rank Sector Weight
1 Technology 25.43%
2 Financials 15.27%
3 Healthcare 11.66%
4 Industrials 10.93%
5 Consumer Staples 10%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WERN icon
51
Werner Enterprises
WERN
$2.23B
$2.42M 0.48%
91,942
-12,093
-12% -$339K
TXN icon
52
Texas Instruments
TXN
$246B
$2.37M 0.46%
12,876
+21
+0.2% +$4.11K
NEE icon
53
NextEra Energy
NEE
$181B
$2.3M 0.45%
30,432
+5,401
+22% +$395K
ENVA icon
54
Enova International
ENVA
$6.44B
$2.26M 0.44%
19,617
-2,385
-11% -$273K
MDT icon
55
Medtronic
MDT
$111B
$2.16M 0.42%
22,633
+5,512
+32% +$507K
BA icon
56
Boeing
BA
$185B
$2.15M 0.42%
9,960
-370
-4% -$83.4K
PFE icon
57
Pfizer
PFE
$143B
$2.09M 0.41%
82,120
+1,903
+2% +$47K
TECH icon
58
Bio-Techne
TECH
$11.2B
$2.08M 0.41%
37,380
-3,100
-8% -$166K
ISRG icon
59
Intuitive Surgical
ISRG
$135B
$2.05M 0.4%
4,589
+1,819
+66% +$873K
META icon
60
Meta Platforms (Facebook)
META
$1.5T
$2.02M 0.4%
2,756
-439
-14% -$327K
PSA icon
61
Public Storage
PSA
$60.9B
$1.95M 0.38%
6,738
+129
+2% +$37K
SNA icon
62
Snap-on
SNA
$21.2B
$1.86M 0.37%
5,379
+4
+0.1% +$1.31K
BLK icon
63
Blackrock
BLK
$175B
$1.83M 0.36%
1,574
+308
+24% +$344K
DIS icon
64
Walt Disney
DIS
$170B
$1.78M 0.35%
15,520
-2,335
-13% -$275K
COF icon
65
Capital One
COF
$134B
$1.77M 0.35%
8,306
-132
-2% -$28.9K
PSX icon
66
Phillips 66
PSX
$82.7B
$1.74M 0.34%
12,768
+70
+0.6% +$8.97K
ORCL icon
67
Oracle
ORCL
$409B
$1.67M 0.33%
5,927
-283
-5% -$72.1K
UNH icon
68
UnitedHealth
UNH
$377B
$1.58M 0.31%
4,573
+2,210
+94% +$668K
EXPD icon
69
Expeditors International
EXPD
$22.3B
$1.54M 0.3%
12,551
-100
-0.8% -$11.9K
PG icon
70
Procter & Gamble
PG
$338B
$1.44M 0.28%
9,400
+2
+0% +$312
DLR icon
71
Digital Realty Trust
DLR
$70.7B
$1.43M 0.28%
8,271
+791
+11% +$135K
GE icon
72
GE Aerospace
GE
$383B
$1.41M 0.28%
4,672
+2
+0% +$547
PNR icon
73
Pentair
PNR
$10.7B
$1.4M 0.28%
12,654
-266
-2% -$28.4K
BRK.B icon
74
Berkshire Hathaway Class B
BRK.B
$1.11T
$1.36M 0.27%
2,700
SBUX icon
75
Starbucks
SBUX
$118B
$1.26M 0.25%
14,874
-140
-0.9% -$12.5K

Similar funds

Rowlandmiller & Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Rowlandmiller & Partners held 194 positions worth $509M, up 5.1% from $485M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Rowlandmiller & Partners's Q3 2025 filing shows 7 new, 51 increased, 69 reduced and 7 closed positions. Its largest new stake was T-Mobile US: 1,895 shares worth $454K. The largest sale was Progressive, an estimated $1.49M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

  • Rowlandmiller & Partners's largest Q3 2025 buy was T-Mobile US: 1,895 shares worth $454K.
  • Rowlandmiller & Partners added most to Intuitive Surgical in Q3 2025, an estimated $873K increase.
  • Rowlandmiller & Partners's biggest Q3 2025 reduction was Progressive, cutting an estimated $1.49M.
  • Rowlandmiller & Partners fully exited Regions Financial in Q3 2025, selling an estimated $384K.
  • Rowlandmiller & Partners's ten largest holdings make up 38% of its $509M portfolio in Q3 2025.
  • Rowlandmiller & Partners opened 7 new positions and closed 7 in Q3 2025.
  • Rowlandmiller & Partners's portfolio value rose 5.1% quarter-over-quarter to $509M.

Based on Rowlandmiller & Partners's 13F filing for Q3 2025, filed 1 Oct 2025.